UNSPSC 85642915: Replacement of pelvic region subcutaneous tissue and fascia with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of pelvic region subcutaneous tissue and fascia with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JRC07Z

UNSPSC 85642915 Replacement of pelvic region subcutaneous tissue and fascia with autologous tissue substitute, open approach is a Commodity code that shows minimal direct alignment with recent state and local procurement activity. The code's nominal scope—a highly specific surgical procedure—does not match the work actually being solicited by state and local bodies in the recent opportunities block. Instead, the opportunities posted under this code span medical evaluation services, pharmacy benefit management, occupational health surveillance, and temporary clinical staffing—none of which involve the pelvic reconstruction procedure the code nominally describes. This mismatch suggests the code has been applied inconsistently or that the opportunities are tagged incorrectly in the source system.

The recent solicitations instead reflect demand from city retirement offices, county health systems, state transportation agencies, and county health consortiums for administrative health services and staffing. The City of Phoenix Retirement Office sought disability medical record review and independent medical examinations (RFP RTMRFP26001, due October 16, 2026); the Washington State Department of Transportation requested occupational medical surveillance across 14 ferry locations (RFP RFP20260825, due October 9, 2026); the County of Santa Clara Health System established a qualified-vendor pool for temporary ancillary clinical staffing (RFQ RFSQHHSFY270052, due October 7, 2026); and Collier County sought pharmacy benefit management services covering approximately 7,200 covered lives with an estimated annual spend of $8.7 million (RFP 25-8414, deadline April 9, 2026). The code shows little relevant recent activity for firms pursuing contracts aligned with the nominal surgical procedure scope.